Alkermes Inc. plc (ALKS) Dividend History

Company News

• 6 Analysts Assess Alkermes: What You Need To Know - Benzinga

  Alkermes (NASDAQ:ALKS) was analyzed by 6 analysts in the last quarter, with a range of viewpoints from bullish to bearish. The analysts provided an average 12-month price target of $36.33, with a high of $48.00 and a low of $31.00. The article also provides financial insights into Alkermes, including its market capitalization, revenue growth, net margin, and debt management.

  Benzinga
• Orchestra BioMed Holdings, Inc. (OBIO) Stock Jumps 7.3%: Will It Continue to Soar?

  Orchestra BioMed Holdings, Inc. (OBIO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

  Zacks Investment Research

  Featured Companies: OBIO
• Here's a 'solid contrarian idea' for 2024, according to BTIG's Krinsky

  Investors should consider this list of healthcare stocks for 2024

  MarketWatch

  Featured Companies: AAPL ABBV ABT AMC APGE BHVN BSX CING CSTL DHR ENSG EXEL FTRE GME IQV ITGR LH LLY MARA NEO NTRA NVDA PFE PGNY PSCH SLP SOPH SYK TSLA XLV
• Why Alkermes Stock Is Sinking Today

  The biotech company's Q3 revenue and earnings looked great, but the results weren't enough to wow investors.

  The Motley Fool